ResMed | RMD - 营业费用

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	营业费用	更改		日
Ansell	USD 880.1M		465.65M	2025-12
Artivion	USD 111.2M		9.45M	2025-12
AtriCure	USD 140.72M		2.71M	2026-03
Baxter International	USD 6.04B		2.85B	2026-03
Cochlear	AUD 914.9M		454.8M	2025-12
Cooper Companies	USD 811.3M		113.5M	2025-12
CSL	USD 5.7B		2.82B	2025-12
Dexcom	USD 936.6M		0	2026-03
Edwards Lifesciences	USD 1.13B		65.4M	2026-03
Fisher Paykel Healthcare	NZD 802.4M		24.1M	2025-12
Globus Medical	USD 595.85M		49.26M	2026-03
Haemonetics	USD 134.99M		1.26M	2025-12
Idexx Laboratories	USD 778.23M		3.26M	2026-03
Inogen	USD 49.14M		665K	2024-09
Insulet	USD 639.7M		2.2M	2026-03
Integra LifeSciences	USD 1.04B		673.49M	2026-03
Intuitive Surgical	USD 1.91B		89.8M	2026-03
Masimo	USD 326.2M		2.4M	2026-03
Medtronic	USD 7.28B		16M	2025-12
Philips	EUR 3.6B		775M	2026-03
Ramsay Health Care	AUD 8.8B		83.5M	2025-12
ResMed	USD 925.74M		525K	2026-03
Sigma Healthcare	AUD 1.68B		174.89M	2024-12
Sonic Healthcare	AUD 4.23B		2.14B	2024-12
Steris	USD 1.27B		51.5M	2026-03
Teleflex	USD 3.08B		2.55B	2026-03
Thermo Fisher Scientific	USD 9.09B		821M	2026-03